- Home
- PGC vs SVRA Comparison
PGC vs SVRA Comparison
Compare PGC & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGC
- SVRA
- Stock Information
- Founded
- PGC 1921
- SVRA 2007
- Country
- PGC United States
- SVRA United States
- Employees
- PGC N/A
- SVRA N/A
- Industry
- PGC Commercial Banks
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- PGC Finance
- SVRA Health Care
- Exchange
- PGC Nasdaq
- SVRA Nasdaq
- Market Cap
- PGC 510.8M
- SVRA 528.3M
- IPO Year
- PGC N/A
- SVRA N/A
- Fundamental
- Price
- PGC $27.42
- SVRA $2.28
- Analyst Decision
- PGC Strong Buy
- SVRA Buy
- Analyst Count
- PGC 2
- SVRA 7
- Target Price
- PGC $38.50
- SVRA $7.57
- AVG Volume (30 Days)
- PGC 84.9K
- SVRA 2.5M
- Earning Date
- PGC 07-22-2025
- SVRA 05-13-2025
- Dividend Yield
- PGC 0.73%
- SVRA N/A
- EPS Growth
- PGC N/A
- SVRA N/A
- EPS
- PGC 1.80
- SVRA N/A
- Revenue
- PGC $227,831,000.00
- SVRA N/A
- Revenue This Year
- PGC $29.32
- SVRA N/A
- Revenue Next Year
- PGC $17.18
- SVRA N/A
- P/E Ratio
- PGC $15.23
- SVRA N/A
- Revenue Growth
- PGC 9.82
- SVRA N/A
- 52 Week Low
- PGC $20.30
- SVRA $1.89
- 52 Week High
- PGC $37.88
- SVRA $5.11
- Technical
- Relative Strength Index (RSI)
- PGC 45.06
- SVRA 36.20
- Support Level
- PGC $27.01
- SVRA $1.89
- Resistance Level
- PGC $28.03
- SVRA $3.18
- Average True Range (ATR)
- PGC 0.72
- SVRA 0.21
- MACD
- PGC -0.15
- SVRA -0.11
- Stochastic Oscillator
- PGC 32.22
- SVRA 29.77
About PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.